Skip to main content

Table 6 Stepwise multiple linear regression analysis of SF-36 domains in gout patients

From: Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study

  β SE t P B (95% CI) F Adj R2
Lower Upper
PCS        15.779 0.247
 Depression (PHQ-9 ≥ 10 score) −16.649 3.693 −4.508 <0.001 −23.928 −9.370   
 Total pain (VAS) −1.551 .372 −4.165 <0.001 −2.285 −0.817   
 Cardiovascular disease −12.562 4.342 −2.894 0.004 −21.119 −4.006   
 Number of flares/last year −0.129 0.058 −2.226 0.027 −0.244 −0.015   
 Colchicine −5.772 2.666 −2.165 0.031 −11.026 −0.518   
MCS        14.686 0.267
 Depression (PHQ-9 ≥ 10 score) −14.268 3.967 −3.596 <0.001 −22.088 −6.449   
 Presence of tender joints, yes −8.333 3.388 −2.460 0.015 −15.010 −1.657   
 Corticosteroids −7.758 2.581 −3.006 0.003 −12.844 −2.671   
 Total pain (VAS) −0.848 0.353 −2.404 0.017 −1.544 −0.153   
 Anxiety (GAD-7 ≥ 10 score) −13.452 6.102 −2.204 0.029 −25.477 −1.426   
  1. VAS: visual analog scale; PHQ-9: patient health questionnaire; GAD-7: generalized anxiety disorder; SF-36: the Short Form 36 Health Survey; PCS: physical components summary; MCS: mental components summary
  2. p values were obtained with stepwise multiple linear regression analysisanalysis
  3. P numbers of entries with significance are shown in italics